Seraxis and Sernova Announce Appointment of Former FDA Medical Officer Dr. Patricia Beaston as Chief Medical Officer of Seraxis and Post Merger BetaNova Biotherapeutics

Go back to Seraxis and Sernova Announce Appointment of Former FDA Medical Officer Dr. Patricia Beaston as Chief Medical Officer of Seraxis and Post Merger BetaNova Biotherapeutics
Sernova Corp Common Shares (AMEX: SEOVF) Delayed: 0.09 --0 (-0%)
Previous Close $0.09    52 Week High $0.31 
Open $0.09    52 Week Low $0.16 
Day High $0.09    P/E N/A 
Day Low $0.09    EPS $0.00 
Volume 78,979       

Sinovac Biotech, Ltd (NASDAQ: SVA) Delayed: 6.47 --0 (-0%)
Previous Close $6.47    52 Week High $7.16 
Open $0.08    52 Week Low $4.38 
Day High $6.47    P/E N/A 
Day Low $6.47    EPS $-0.08 
Volume 39,200